Replies to post #216781 on Biotech Values

[DewDiligence]

ABT 4Q17 sales by business segment:

 Medical devices  36% (+10% YoY) 
 Nutrition        24% ( +2% YoY)  
 Diagnostics      25% ( +7% YoY) 
 Pharmaceuticals† 15% (+14% YoY)

65% of overall sales were ex-US.

†Ex-US branded generics.